Clinical Institute Withdrawal Assessment – Benzodiazepine (CIWA-B): Description, strengths and knowledge gaps

Jane Fischer, Ann Roche, Vinita Duraisingam

    Research output: Other contribution

    Abstract

    Standardised tools are important for safely monitoring psychoactive drug use withdrawal. As part of the development of an online collection of commonly used AOD withdrawal tools, a desktop review of the Clinical Institute Withdrawal Assessment – Benzodiazepine (CIWA-B) was conducted to ascertain appropriate populations, diagnostics, utility, resources and knowledge gaps. This overview is the result of that review.
    Original languageEnglish
    TypeDesktop Review: Withdrawal Instrument – CIWA-B
    Media of outputPrimarily Electronic PDF
    PublisherNational Centre for Education and Training on Addiction, Flinders University.
    Number of pages5
    Place of PublicationSouth Australia
    Publication statusPublished - 30 Jun 2021

    Publication series

    NameAOD Screening & Withdrawal Tools Collection

    Keywords

    • withdrawal symptoms
    • Drug and alcohol use
    • review
    • benzodiazepine
    • CIWA-B

    Fingerprint

    Dive into the research topics of 'Clinical Institute Withdrawal Assessment – Benzodiazepine (CIWA-B): Description, strengths and knowledge gaps'. Together they form a unique fingerprint.

    Cite this